Aggressive end-of-life (EOL) care is associated with lower quality of life and greater regret about treatment decisions. Higher EOL costs are also associated with lower quality EOL care. Advance care planning and goals-of-care conversations (“EOL discussions”) may influence EOL health-care utilization and costs among persons with cancer.
Objective:
To describe associations among EOL discussions, health-care utilization and place of death, and costs in persons with advanced cancer and explore variation in study measures.
Methods:
A systematic review was conducted using PubMed, Embase, and CINAHL. Twenty quantitative studies published between January 2012 and January 2019 were included.
Results:
End-of-life discussions are associated with lower health-care costs in the last 30 days of life (median US$1048 vs US$23482; P < .001); lower likelihood of acute care at EOL (odds ratio [(OR] ranging 0.43-0.69); lower likelihood of intensive care at EOL (ORs ranging 0.26-0.68); lower odds of chemotherapy near death (ORs 0.41, 0.57); lower odds of emergency department use and shorter length of hospital stay; greater use of hospice (ORs ranging 1.79 to 6.88); and greater likelihood of death outside the hospital. Earlier EOL discussions (30+ days before death) are more strongly associated with less aggressive care outcomes than conversations occurring near death.
Conclusions:
End-of-life discussions are associated with less aggressive, less costly EOL care. Clinicians should initiate these discussions with patients having cancer earlier to better align care with preferences.
Lopez-AcevedoMHavrileskyLJBroadwaterG, et al.Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer. Gynecol Oncol. 2013;130(1):156–161.
2.
WachtermanMWPilverCSmithDErsekMLipsitzSRKeatingNL. Quality of end-of-life care provided to patients with different serious illnesses. JAMA Intern Med. 2016;176(8):1095–1102.
3.
GieniuszMNunesRSahaVRensonASchubertFCareyJ. Earlier goals of care discussions in hospitalized terminally ill patients and the quality of end-of-life care: a retrospective study. Am J Hosp Palliat Care. 2018;35(1):21–27.
4.
Smith-HowellERHickmanSEMeghaniSHPerkinsSMRawlSM. End-of-life decision making and communication of bereaved family members of African Americans with serious illness. J Palliat Med. 2016;19(2):174–182.
5.
ChastekBHarleyCKallichJNewcomerLPaoliCJTeitelbaumAH. Health care costs for patients with cancer at the end of life. J Oncol Pract. 2012;8(6):75s–80s.
6.
ZhangBWrightAAHuskampHA, et al.Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med. 2009;169(5):480–488.
7.
ObermeyerZMakarMAbujaberSDominiciFBlockSCutlerDM. Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer. JAMA. 2014;312(18):1888–1896.
8.
CheungMCEarleCCRangrejJ, et al.Impact of aggressive management and palliative care on cancer costs in the final month of life. Cancer. 2015;121(18):3307–3315.
9.
ZafarSYPeppercornJMSchragD, et al.The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist. 2013;18(4):381–390.
10.
RamseySBloughDKirchhoffA, et al.Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood). 2013;32(6):1143–1152.
11.
ArozullahAMCalhounEAWolfM, et al.The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. 2004;2(3):271–278.
12.
SharpLCarsinAETimmonsA. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psycho-Oncology. 2013;22(4):745–755.
13.
GordonLGMerolliniKMDLoweAChanRJ. A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. Patient. 2017;10(3):295–309.
14.
CagleJGCarrDCHongSZimmermanS. Financial burden among US households affected by cancer at the end of life. Psychooncology. 2016;25(8):919–926.
15.
O’ConnorNRJunkerPAppelSMStetsonRLRohrbachJMeghaniSH. Palliative care consultation for goals of care and future acute care costs: a propensity-matched study. Am J Hosp Palliat Care. 2017;35(10):966–971.
16.
Institute of Medicine (IOM). Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Washington, DC: IOM; 2015.
17.
FerrellBRTemelJSTeminS, et al.Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline update. J Clin Oncol. 2017;35(1):96–112.
18.
Schulman-GreenDSmithCBLinJJFederSBickellNA. Oncologists’ and patients’ perceptions of initial, intermediate, and final goals of care conversations. J Pain Symptom Manage. 2017;55(3):890–896.
19.
HoubenCHMSpruitMAGroenenMTJWoutersEFMJanssenDJA. Efficacy of advance care planning: a systematic review and meta-analysis. J Am Med Dir Assoc. 2014;15(7):477–489.
20.
KayeDRMinHSHerrelLADupreeJMEllimoottilCMillerDC. Costs of cancer care across the disease continuum. Oncologist. 2018;23(7):798–805.
21.
HaynesMASmedleyBD. The unequal burden of cancer: an assessment of NIH research and programs for ethnic minorities and the medically underserved. In: HaynesMASmedleyBD, eds. The Unequal Burden of Cancer: An Assessment of NIH Research and Programs for Ethnic Minorities and the Medically Underserved. Washington, DC: Institute of Medicine, NIH; 1999.
22.
BernackiREBlockSD; American College of Physicians High Value Care Task Force. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med. 2014;174(12):1994–2003.
23.
MackJWCroninAKeatingNL, et al.Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol. 2012;30(35):4387–4395.
24.
DalalSBrueraE. End-of-life care matters: palliative cancer care results in better care and lower costs. Oncologist. 2017;22(4):361–368.
25.
KlinglerCin der SchmittenJMarckmannG. Does facilitated advance care planning reduce the costs of care near the end of life? Systematic review and ethical considerations. Palliat Med. 2016;30(5):423–433.
ZafarSYAbernethyAP. Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park). 2013;27(2):80–81, 149.
29.
JimenezGTanWSVirkAKLowCKCarJHoAHY. Overview of systematic reviews of advance care planning: summary of evidence and global lessons. J Pain Symptom Manage. 2018;56(3):436–459e425.
30.
WeathersEO’CaoimhRCornallyN, et al.Advance care planning: a systematic review of randomised controlled trials conducted with older adults. Maturitas. 2016;91:101–109.
31.
AhluwaliaSCTisnadoDMWallingAM, et al.Association of early patient-physician care planning discussions and end-of-life care intensity in advanced cancer. J Palliat Med. 2015;18(10):834–841.
32.
ApostolCCWaldfogelJMPfohER, et al.Association of goals of care meetings for hospitalized cancer patients at risk for critical care with patient outcomes. Palliat Med. 2015;29(4):386–390.
33.
CappellKSundaramVParkA, et al.Advance directive utilization is associated with less aggressive end-of-life care in patients undergoing allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2018;24(5):1035–1040.
34.
DollKMStineJEVan LeL, et al.Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients. Gynecol Oncol. 2013;130(1):152–155.
35.
EckhertEESchoenbeckKLGalliganDMcNeyLMHwangJMannisGN. Advance care planning and end-of-life care for patients with hematologic malignancies who die after hematopoietic cell transplant. Bone Marrow Transplant. 2017;52(6):929–931.
36.
GarridoMMBalboniTAMaciejewskiPKBaoYPrigersonHG. Quality of life and cost of care at the end of life: the role of advance directives. J Pain Symptom Manage. 2015;49(5):828–835.
37.
GarridoMMPrigersonHGBaoYMacIejewskiPK. Chemotherapy use in the months before death and estimated costs of care in the last week of life. J Pain Symptom Manage. 2016;51(5):875–881.e872.
38.
GramlingRIngersollLTAndersonW, et al.End-of-life preferences, length-of-life conversations, and hospice enrollment in palliative care: a direct observation cohort study among people with advanced cancer. J Palliat Med. 2018;22(2):152–156.
39.
HoergerMGreerJAJacksonVA, et al.Defining the elements of early palliative care that are associated with patient-reported outcomes and the delivery of end-of-life care. J Clin Oncol. 2018;36(11):1096–1102.
40.
LoggersETMaciejewskiPKJimenezR, et al.Predictors of intensive end-of-life and hospice care in Latino and white advanced cancer patients. J Palliat Med. 2013;16(10):1249–1254.
41.
MarciaLAshmanZWPilladoEBKimDYPluradDS. Advance directive and do-not-resuscitate status among advanced cancer patients with acute care surgical consultation. Am Surg. 2018;84(10):1565–1569.
42.
O’ConnorTLNgamphaiboonNGromanA, et al.Hospice utilization and end-of-life care in metastatic breast cancer patients at a comprehensive cancer center. J Palliat Med. 2015;18(1):50–55.
43.
PatelMISundaramVDesaiM, et al.Effect of a lay health worker intervention on goals-of-care documentation and on health care use, costs, and satisfaction among patients with cancer: a randomized clinical trial. JAMA Oncol. 2018;4(10):1359–1366.
44.
PedrazaSKnestrickMCulpSFalkenstineEMossA. Association of post form use with quality end-of-life care metrics in cancer patients: update from the West Virginia registry. J Pain Symptom Manag. 2017;53(2):367–368.
45.
RocqueGBDionne-OdomJNSylvia HuangCH, et al.Implementation and impact of patient lay navigator-led advance care planning conversations. J Pain Symptom Manage. 2017;53(4):682–692.
46.
SharmaRKPrigersonHGPenedoFJMaciejewskiPK. Male-female patient differences in the association between end-of-life discussions and receipt of intensive care near death. Cancer. 2015;121(16):2814–2820.
47.
ZakhourMLaBrantLRimelBJ, et al.Too much, too late: aggressive measures and the timing of end of life care discussions in women with gynecologic malignancies. Gynecol Oncol. 2015;138(2):383–387.
48.
ZarosMCCurtisJRSilveiraMJElmoreJG. Opportunity lost: end-of-life discussions in cancer patients who die in the hospital. J Hosp Med. 2013;8(6):334–340.
49.
MoherDLiberatiATetzlaffJAltmanDGGroupP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–341.
PedrazaSLCulpSKnestrickMFalkenstineEMossAH. Association of physician orders for life-sustaining treatment form use with end-of-life care quality metrics in patients with cancer. J Oncol Pract. 2017;13(10):e881–e888.
52.
SchmidtTAZiveDFrommeEKCookJNTolleSW. Physician Orders for Life-Sustaining Treatment (POLST): lessons learned from analysis of the Oregon POLST registry. Resuscitation. 2014;85(4):480–485.
53.
ZhangBNilssonMEPrigersonHG. Factors important to patients’ quality of life at the end of life. Arch Intern Med. 2012;172(15):1133–1142.
54.
MackJWPaulkMEViswanathKPrigersonHG. Racial disparities in the outcomes of communication on medical care received near death. Arch Intern Med. 2010;170(17):1533–1540.
55.
SmithAKMcCarthyEPPaulkE, et al.Racial and ethnic differences in advance care planning among patients with cancer: impact of terminal illness acknowledgment, religiousness, and treatment preferences. J Clin Oncol. 2008;26(25):4131–4137.
56.
TrueGPhippsEJBraitmanLEHarralsonTHarrisDTesterW. Treatment preferences and advance care planning at end of life: the role of ethnicity and spiritual coping in cancer patients. Ann Behav Med. 2005;30(2):174–179.
57.
ZafarSYChinoFUbelPA, et al.The utility of cost discussions between patients with cancer and oncologists. Am J Manag Care. 2015;21(9):607–615.
